- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Kielo Research GmbH
Kielo Research GmbH is listed as a small business research supplier in the Scientist.com network, with 3 sites in 2 countries.
View Kielo Research GmbH on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
3
Countries
2
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Clinical Trials
- eCOA - Electronic Clinical Outcomes Assessments Use smartphones, computers and tablets to allow patients to directly report health outcomes.
- ePRO - Electronic Patient-reported Outcome Patient reported outcome collected by electronic methods.
- Wearables / Remote Patient Monitoring Source medical-grade or consumer-grade devices that track patients' vital signs and other health data remotely and wirelessly transmit this information to healthcare providers
Data Science/Bioinformatics
- RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
- RWE/HEOR Drug/Therapy Discontinuation Analysis An analysis to understand patient behavior. Are the drugs taken on time, do the patients discontinue use, and if so how long after starting, etc.
HEOR
- Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
- Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
- Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
- Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
Show all 10 in HEOR
- Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
- Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Market Access
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Show all 44 services
Medical Communications
- Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
- HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
- KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
- Patient Advocacy Group Engagement Compliant collaboration and information sharing with non-profit organizations that represent patient communities to understand their needs and provide education.
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
Old Category HEOR, RWE, Market Access
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
- Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
- RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Primary Market Research
- Adherence, Satisfaction, and Switch Behavior Studies Explores factors driving treatment compliance, satisfaction, and switching behavior. Guides patient support initiatives and product differentiation.
- Focus groups (in-person/virtual) Facilitated group discussions to evaluate reactions to concepts, messages, or services. Produces consensus insights and contrasting views used to refine strategy, materials, or offerings.
- In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
- Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
Real World Evidence & Data
- Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
- Retrospective Exploratory Studies Retrospective exploratory studies
Show all 10 in Real World Evidence & Data
- RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
- RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
- RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
- RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
- Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
- Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
- Website
- www.kieloresearch.com
Where it operates
Sites by country, with the cities in each.
-
Switzerland 2 sites
-
United Kingdom 1 site
Work with Kielo Research GmbH on Scientist.com
For prices, more details, or to contact Kielo Research GmbH, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.